Results 111 to 120 of about 2,525 (153)

Activity of cefiderocol against <i>Pseudomonas aeruginosa</i> from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those nonsusceptible to recently developed β-lactam/β-lactamase inhibitor combinations: results from the SENTRY antimicrobial surveillance program. [PDF]

Microbiol Spectr
Kimbrough JH, Karr MH, Nguyen ST, DeJonge BLM, Longshaw C, Takemura M, Yamano Y, Castanheira M, Mendes RE.   +8 more
europepmc   +1 more source

Structural insights into the activity of carbapenemases: understanding the mechanism of action of current inhibitors and informing the design of new carbapenem adjuvants. [PDF]

RSC Med Chem
Hatzisarantinos T, Mansour E, Du JJ, Fares M, Hibbs DE, Groundwater PW.   +5 more
europepmc   +1 more source

First nationwide survey on <i>Pseudomonas aeruginosa</i> in Bolivia: susceptibility profiles, resistome, and genomic epidemiology. [PDF]

Antimicrob Agents Chemother
Alvarado-Orosco N, Gomis-Font MA, Sastre-Femenia MA, Ribera Ortiz S, Miranda Arce M, Araúz Barba ME, Navia Durán MdR, Vargas Nattez SG, Cabellos Astorga G, Villarroel Rodriguez PJ, Almaraz Roca DD, Castillo Cruz M, Chambi Condori JP, Quevedo Ribera P, Patino García SM, Contreras Otalora Y, Rosales Rea FM, Portugal Gutiérrez CM, Sánchez Serrano M, López-Causapé C, Oliver A.   +20 more
europepmc   +1 more source

Restoring Control: Real-World Success with Imipenem-Relebactam in Critical MDR Infections-A Multicenter Observational Study. [PDF]

Pathogens
Marino A, Pipitone G, Venanzi Rullo E, Cosentino F, Ippolito R, Costa R, Bagarello S, Russotto Y, Iaria C, Cacopardo B, Nunnari G.   +10 more
europepmc   +1 more source

Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations. [PDF]

Infect Drug Resist
Gatti M, Pea F.
europepmc   +1 more source

CarbaDetector: a machine learning model for detecting carbapenemase-producing Enterobacterales from disk diffusion tests. [PDF]

Nat Commun
Muhsal LK, Cimen C, Sattler J, Theis L, Nolte O, Dortet L, Bonnin RA, Egli A, Hamprecht A.   +8 more
europepmc   +1 more source

Role of Cefiderocol in the Treatment of Carbapenem-Resistant Nonfermenting Gram-Negative Bacilli (Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia) Infections: An Expert Statement. [PDF]

Infect Dis Ther
Bleibtreu A, Bennis Y, Dinh A, Dupont H, Friggeri A, Jeannot K, Kipnis E, Zahar JR, CoRIS Cohort.   +8 more
europepmc   +1 more source

β-Lactam/β-Lactamase Inhibitor Combinations in Sepsis-Associated Acute Kidney Injury and Renal Replacement Therapy. [PDF]

Antibiotics (Basel)
Lacquaniti A, Pistolesi V, Smeriglio A, Santoro D, Iannetti C, Lentini G, Chimenz R, Chirico V, Trombetta D, Morabito S, Monardo P.   +10 more
europepmc   +1 more source

Comparative evaluation of five β-Lactamase inhibitors in combination with β-Lactams against multidrug-resistant Mycobacterium tuberculosis in vitro. [PDF]

BMC Infect Dis
Shi J, Zheng D, Su R, Ma X, Zhu Y, Wang S, Chang W, Sun D.   +7 more
europepmc   +1 more source